Poland Attention Deficit Hyperactivity Disorder Therapeutic Market Report 2022 to 2030

Poland ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis

$ 3999

Poland's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $171 Mn in 2022 to $316 Mn in 2030 with a CAGR of 7.95% for the year 2022-2030. The increased prevalence of ADHD and the availability of novel therapeutic options for the treatment of ADHD in Poland are the major market drivers for the growth of the market. The Poland ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market are ALG Pharma, Techdow Pharma, and Noven Pharmaceuticals.

ID: IN10PLPH028 CATEGORY: Pharmaceuticals GEOGRAPHY: Poland AUTHOR: Parul Choudhary

Buy Now

Poland Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Executive Analysis

The Poland Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market size is at around $171 Mn in 2022 and is projected to reach $316 Mn in 2030, exhibiting a CAGR of 7.95% during the forecast period. The health minister for Poland stated that the nation is methodically moving toward allocating 7% of its GDP to healthcare. Adam Niedzielski added that the government's plans had been expanded by an additional $9.72 Bn. From $17.44 Bn in 2015 to $36.06 Bn in 2023, expenses will increase. The amount spent on healthcare will increase to 7% of GDP by 2027, according to a parliament amendment to the act on healthcare funded with public funds that were approved in August 2021.

The neurobehavioral condition known as ADHD, which first appears in children, is defined by a combination of hyperactivity, impulsivity, and/or inattention. According to some studies, ADHD affects between 3% and 7% of the population in Poland, which is considered to be a reasonably high prevalence. At least two aspects of the child's existence, such as the home and the classroom, are significantly impacted by these symptoms. At the moment, there are four main kinds of ADHD (predominantly inattentive, predominantly hyperactive-impulsive, combined, and unspecified). In Poland, stimulant drugs like methylphenidate and amphetamines as well as non-stimulant drugs like atomoxetine are used as pharmacological therapies for ADHD. These drugs function by raising the levels of specific neurotransmitters in the brain that are associated with impulse control and focus. Only a licensed healthcare expert may prescribe these medications, which are only available with a prescription. In Poland, behavioral therapies such as cognitive-behavioral counseling, parent education, and social skills training are possible non-pharmacological treatments for ADHD. These therapies work to enhance the planning, time management, and social interaction behaviors and skills that are impacted by ADHD. Although their efficacy is not well-established and they are not regarded as conventional treatments, some people with ADHD in Poland may also use alternative treatments like dietary supplements.

poland attention deficit hyperactivity disorder therapeutics market analysis

Market Dynamics

Market Growth Drivers

The Poland ADHD therapeutics market is expanding as more people are receiving diagnoses for the disease as a result of increased awareness of ADHD. It's possible that more individuals in Poland will seek treatment for ADHD as healthcare access improves. The development of new, more potent ADHD medications may boost consumer demand and propel market expansion. Government programs, such as research funding or treatment cost subsidies, that aim to enhance ADHD diagnosis and treatment may also help the Poland ADHD therapeutics market expand.

Market Restraints

In Poland, there might be a stigma attached to ADHD that discourages people from getting help or disclosing their condition. Some patients, especially those without health insurance or with limited financial resources, may find the cost of ADHD treatments to be a barrier. The market for conventional pharmacological treatments for ADHD may be constrained by rivalry from complementary therapies, such as behavioral counseling or dietary supplements.

Competitive Landscape

Key Players

SymPhar (POL)
Suplemed (POL)
Topmedex (POL)
ALG Pharma (POL)
Techdow Pharma (POL)
Noven Pharmaceuticals
Otsuka Pharmaceutical
Purdue Pharma
RespireRx Pharmaceuticals
Supernus Pharmaceuticals

Healthcare Policies and Regulatory Landscape

The Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products (URPL).is Poland's medication-regulating body. In Poland, URPL oversees a wide range of regulatory activities pertaining to pharmaceuticals, medical devices, and biocidal products. Its main duties include things like Assessing requests for marketing permission for pharmaceuticals, medical devices, and biocides and determining whether to approve them based on safety, efficacy, and quality standards. Through post-marketing surveillance and pharmacovigilance activities, approved pharmaceuticals, medical devices, and biocidal products are being monitored for efficacy and safety. governing the production, import, and dissemination of pharmaceuticals, medical equipment, and biocides in Poland. Enforcing regulatory compliance and conducting the necessary enforcement actions against non-compliant distributors or manufacturers.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Segmentation

By Drug Type (Revenue, USD Billion):

Stimulants
- Amphetamine
- Methylphenidate
- Dextroamphetamine
- Dexmethylphenidate
- Lisdexamfetamine
- Others
Non-Stimulants
- Atomoxetine
- Bupropion
- Guanfacine
- Clonidine

By Age Group (Revenue, USD Billion):

Pediatric And Adolescent
Adult

By Distribution Channel (Revenue, USD Billion):

Hospital Pharmacies
Speciality Clinics
Retail Pharmacies
e-Commerce

By Psychotherapy (Revenue, USD Billion):

Behaviour Therapy
Cognitive Behavioral Therapy
Interpersonal Psychotherapy
Family Therapy

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.